Great points. I think Nadar mis spoke about the timing of DR Patterson's paper. But I am very encouraged that he is already working on the infrastructure of providing this to the entire world.

I think we need to make a reasonable profit so we can push more indications forward.

Lastly, I think we are going to get compassionate use in US, followed quickly by UK. This will save many lives, but I am concerned it will slow down enrollment in the trials.

Perhaps the FDA has another plan in mind.